The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Ras controls a multitude of cellular signaling processes, including cell proliferation, differentiation, and apoptosis. Deregulation of Ras cycling often promotes tumorigenesis and various other developmental disorders, termed RASopothies. Although the structure of Ras has been known for many decades, it is still one of the most highly sought-after drug targets today, and is often referred to as "undruggable." At the center of this paradoxical protein is a lack of understanding of fundamental differences in the G domains between the highly similar Ras isoforms and common oncogenic mutations, despite the immense wealth of knowledge accumulated about this protein to date. A shift in the field during the past few years toward a high-resolution understanding of the structure confirms the hypothesis that each isoform and oncogenic mutation must be considered individually, and that not all Ras mutations are created equal. For the first time in Ras history, we have the ability to directly compare the structures of each wild-type isoform to construct a "base-line" understanding, which can then be used as a springboard for analyzing the effects of oncogenic mutations on the structure-function relationship in Ras. This is a fundamental and large step toward the goal of developing personalized therapies for patients with Ras-driven cancers and diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
A Comprehensive Survey of Ras Mutations in Cancer
Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063 · cited 3×
“Yet, there has been moderate success for small molecules designed to covalently target the G12C oncogenic mutation in Ras, especially important for the goal of selectively targeting prominent mutations linked to specific cancer types, in this case lung adenocarcinoma (Prior et al. 2012).”
BackgroundMethodSelf-citationGEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903 · cited 2×
“In the context of cellular signaling, Ras requires the aid of these regulatory proteins to overcome its high affinity for the bound nucleotide and intrinsically slow hydrolysis rate (Ahmadian et al. 1997; Boriack-Sjodin et al. 1998; Bos et al. 2007).”
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · cited 1×
“Molecular dynamics (MD) simulations support these nucleotide-dependent shifts in the conformational ensemble of Ras (Grant et al. 2009; Raimondi et al. 2011).”
BackgroundThe Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543 · cited 1×
“The negatively charged D12 side chain would clash with both the arginine finger and catalytically important residue Q61 and thus interfere with both GAPmediated and intrinsic hydrolysis, respectively, of GTP to GDP on Ras (Franken et al. 1993; Scheffzek et al. 1997).”
BackgroundRAS isoforms and mutations in cancer at a glance
Hobbs, G. A., Der, C. J., & Rossman, K. L. (2016) · Journal of Cell Science · doi:10.1242/jcs.182873 · Cited by 973
The structural basis of the activation of Ras by Sos
Boriack-Sjodin, P. A., Margarit, S. M., Bar-Sagi, D., & Kuriyan, J. (1998) · Nature · doi:10.1038/28548 · Cited by 799 · cited 2×
“In the context of cellular signaling, Ras requires the aid of these regulatory proteins to overcome its high affinity for the bound nucleotide and intrinsically slow hydrolysis rate (Ahmadian et al. 1997; Boriack-Sjodin et al. 1998; Bos et al. 2007).”
BackgroundMaurer, T., Garrenton, L. S., Oh, A., Pitts, K., Anderson, D. J., Skelton, N. J., Fauber, B. P., Pan, B., Malek, S., Stokoe, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116510109 · Cited by 618
Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated Activation
Sun, Q., Burke, J. P., Phan, J., Burns, M. C., Olejniczak, E. T., Waterson, A. G., Lee, T., Rossanese, O. W., & Fesik, S. W. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201358 · Cited by 490 · cited 1×
“Other small molecules have been shown to bind to the outer switch II region of GDP-bound Ras, in which they interfere with the GEF-mediated nucleotide exchange to keep Ras in its signalinginactive conformation (Maurer et al. 2012; Sun et al. 2012).”
BackgroundKinetics of interaction of nucleotides with nucleotide-free H-ras p21
John, J., Sohmen, R., Feuerstein, J., Linke, R., Wittinghofer, A., & Goody, R. S. (1990) · Biochemistry · doi:10.1021/bi00477a025 · Cited by 429
Therapeutic Targeting of Oncogenic K‐Ras by a Covalent Catalytic Site Inhibitor
Lim, S. M., Westover, K. D., Ficarro, S. B., Harrison, R. A., Choi, H. G., Pacold, M. E., Carrasco, M., Hunter, J., Kim, N. D., Xie, T., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307387 · Cited by 300
Inhibition of RAS function through targeting an allosteric regulatory site
Spencer-Smith, R., Koide, A., Zhou, Y., Eguchi, R. R., Sha, F., Gajwani, P., Santana, D., Gupta, A., Jacobs, M., Herrero-Garcia, E., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2231 · Cited by 283
The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B
Lu, S., Jang, H., Nussinov, R., & Zhang, J. (2016) · Scientific Reports · doi:10.1038/srep21949 · Cited by 219 · cited 2×
“However, targeting the protein–protein interaction (PPI) interface on Ras, which includes both dynamic switch I and switch II regions and is large and relatively flat, presents challenges for traditional small molecules (Lu et al. 2016b).”
BackgroundDrugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Lu, S., Jang, H., Gu, S., Zhang, J., & Nussinov, R. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00911a · Cited by 188 · cited 2×
“However, targeting the protein–protein interaction (PPI) interface on Ras, which includes both dynamic switch I and switch II regions and is large and relatively flat, presents challenges for traditional small molecules (Lu et al. 2016b).”
BackgroundSpoerner, M., Hozsa, C., Poetzl, J. A., Reiss, K., Ganser, P., Geyer, M., & Kalbitzer, H. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145235 · Cited by 148 · cited 6×
“The predominance of state 2 in WT H-Ras found both in the crystal structures and by 31P nuclear magnetic resonance (NMR) (Spoerner et al. 2010) contrasts with theWTK-Ras crystal structure with an open switch I conformation consistent with a more exposed P-loop as determined by recently published hydrogen/deuterium exc…”
BackgroundInfluentialJohnson, C. W., Reid, D., Parker, J. A., Salter, S., Knihtila, R., Kuzmic, P., & Mattos, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.778886 · Cited by 133 · cited 6×
“3D) (Johnson et al. 2017).”
BackgroundInfluentialSelf-citationIntegrated RAS signaling defined by parallel NMR detection of effectors and regulators
Smith, M. J., & Ikura, M. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1435 · Cited by 87 · cited 1×
“Specifically, this level of regulation may be important in the context of Raf binding, which can outcompete GAP binding because of its nanomolar affinity for Ras-GTP (Smith and Ikura 2014).”
BackgroundRAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
Miller, M. S., & Miller, L. D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2011.00100 · Cited by 76
An engineered protein antagonist of K-Ras/B-Raf interaction
Kauke, M. J., Traxlmayr, M. W., Parker, J. A., Kiefer, J. D., Knihtila, R., McGee, J., Verdine, G., Mattos, C., & Wittrup, K. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-05889-7 · Cited by 64 · cited 4×
“The first example of an inhibitor that takes advantage of differing conformational states between WT and mutant-activated K-Ras has been illustrated by the crystallization of a small engineered binding protein identified by yeast surface display in complex with KRasG12D-GppNHp and WT K-Ras-GppNHp (PDB ID 5UFQ and 5UFE…”
BackgroundInfluentialSelf-citationDifferential dynamics of RAS isoforms in GDP- and GTP-bound states
Kapoor, A., & Travesset, A. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24805 · Cited by 53 · cited 3×
“It is interesting to note that in the inactive GDPbound structures switch I is the most rigid in KRas when comparedwith the other two isoforms (Kapoor and Travesset 2015), suggesting a stable interaction mostly mediated by the canonical Y32-Y40 hydrogen bond observed in all GDPbound Ras structures.”
Background
Cited by
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
Mo, S. P., Coulson, J. M., & Prior, I. A. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180173 · Cited by 85
Structural Learning of Proteins Using Graph Convolutional Neural Networks
Zamora-Resendiz, R., & Crivelli, S. (2019) · doi:10.1101/610444 · Cited by 37
“The Ras family of proteins are of great interest in cancer research [50, 51] as mutations of proteins in this family are thought to contribute to the development of cancers such as pancreatic cancer and colorectal cancer.”
BackgroundInfluentialDynamic Protein Allosteric Regulation and Disease
Nussinov, R., Tsai, C.-J., & Jang, H. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-8719-7_2 · Cited by 18
Duhay, V., Tian, M., Kosieradzka, K., Ebner, M., Lo, W.-T., Krauss, M., Sprengel, H.-L., Voss, M., Riechmann, M., Savas, J. N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70345-y · Cited by 4
Metadata
- Authors
- Parker, J. A., & Mattos, C.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-10-16
- Volume
- 8
- Issue
- 8
- Pages
- a031427
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2766818551
- Cited by
- 61
- References
- 20
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.